Labshake search
Citations for R&D Systems :
101 - 150 of 1909 citations for Caspase 2 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2023Quote: The human ADGF (Recombinant Human Adenosine deaminase 2/CECR1) #7518-AD-010 was from R&D Systems, Minneapolis ...
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...
-
bioRxiv - Immunology 2022Quote: ... caspase-8 (50 μM Z-IETD-FMK, R&D Systems) or caspase-9 inhibitors (50 μM Z-LEHD-FMK ...
-
bioRxiv - Microbiology 2021Quote: ... Mouse IgG2a mAb to CD45 (GAP 8.3) was from ATCC and mouse anti-CD98 mAb was from R&D Systems. Rabbit antibodies (Ab ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant experiments were carried out by using F9 recombinant protein (R&D systems). MCF7 cell line was treated with 10 μg/ml in complete medium for two rounds of 72 hours (total of 6 days treatment) ...
-
bioRxiv - Immunology 2022Quote: ... recombinant IL-21 and/or recombinant both at 25ng/ml (R&D system). On day 7 ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...
-
bioRxiv - Cancer Biology 2022Quote: For recombinant E6 proteins and sdAbs: 2 µg of E6 (R&D Systems Inc., Cat. # AP-120-025), MBP (Abnova ...
-
bioRxiv - Cell Biology 2023Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Developmental Biology 2021Quote: ... SOX2 mouse mAb (1:100; R&D Systems), SOX2 goat (1:100 ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Microbiology 2024Quote: ... Cells were then stained for 30min on ice with Alexa-Fluor-488-conjugated mouse monoclonal antibody (mAb) directed against the SARS-CoV-2 spike protein (R&D systems; clone #1035206 ...
-
bioRxiv - Bioengineering 2024Quote: ... CAR T cells for the initial challenge day 0 imaging experiment were stained with the following antibody mix in FACS buffer (PBS 1x + 2% FCS + 2mM EDTA): anti-RQR8 mAb clone QBEND10-APC (R&D Systems), anti-CD4 mAb clone VIT4-VioBlue (Miltenyi Biotec ...
-
bioRxiv - Bioengineering 2024Quote: ... cells from re-challenge plates were stained with the following antibody mix in FACS buffer (PBS1x + 2% FCS + 2mM EDTA): anti-RQR8 mAb clone QBEND10-APC (R&D Systems), anti-CD4 mAb clone VIT4-VioBlue (Miltenyi Biotec) ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant mouse interferon-γ and recombinant human interkeukin-8 (R&D Systems, Minneapolis, MN) was prepared in PBS containing 0.1% BSA ...
-
bioRxiv - Microbiology 2020Quote: ... Approximately 5000 RU of Recombinant Human Desmoglein-2 Fc Chimera Protein (R&D Systems, Catalogue number 947-DM-100) was amine coupled to a CM5 sensor chip at a slow flow-rate of 10 μl/min to ensure uniform distribution on the chip surface.
-
bioRxiv - Immunology 2022Quote: ... T cells then were washed and further incubated with recombinant human IL-2 (10 ng/ml; R&D systems) for up to 2 weeks at 37°C incubator with medium change every 3 days ...
-
bioRxiv - Cell Biology 2023Quote: ... starved for 2 hours and treated with 10 ng/ml rat recombinant EGF (R&D Systems, Minneapolis, MN, USA) for 5 min ...
-
bioRxiv - Immunology 2021Quote: ... recombinant MBL (R&D systems) (100 µg mL-1 ...
-
bioRxiv - Bioengineering 2022Quote: ... Recombinant LOXL2 (R&D Systems) was used as a positive control.
-
bioRxiv - Bioengineering 2022Quote: ... Immunohistochemical assays for Caspase 3 (1:1000, R&D systems, AF835), PDGFR-β (Santa Cruz Biotechnology ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Immunology 2023Quote: ... human/mouse caspase-3 antibody polyclonal goat IgG (R&D systems) for HCT116 ...
-
bioRxiv - Cancer Biology 2023Quote: The caspase inhibitor sample pack (R&D systems-Cat No FMKAP01); which contained Z-VAD (general caspase inhibitor) ...
-
bioRxiv - Immunology 2022Quote: ... anti-TLR2 mAb (100 μg/ml, R&D system), or a mixture of anti-CLEC5A mAb and anti-TLR2 mAb for 30 min at room temperature before incubation with SARS-CoV-2 ...
-
bioRxiv - Immunology 2022Quote: ... mouse anti-S1 mAb (clone 1035206; R&D Systems) was diluted 1:100 and applied to each well ...
-
bioRxiv - Immunology 2019Quote: ... or isotype control mAb (MAB006; R&D Systems, USA) in 200 μl PBS ...
-
bioRxiv - Microbiology 2020Quote: Mouse anti-human ACE2 mAb (R&D Systems, USA), rat anti-Flag mAb (L5 ...
-
bioRxiv - Immunology 2024Quote: ... anti-CXCL10 or anti-CXCL11 mAb (R&D systems) were added to the lower compartment prior to start of the assay.
-
bioRxiv - Immunology 2023Quote: ... Subsequently the cells were rested and expanded in kool aid complete media for 2 days supplemented with 100 U/mL recombinant Human IL-2 (R&D Systems Cat# 202-IL-010/CF). Subsequently ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant DLL4 (#1389-D4) and recombinant Jagged-1 (#Q63722) were purchased from R&D systems and coated on plates at the same time as anti-CD3/anti-CD28 ...
-
bioRxiv - Immunology 2019Quote: ... cover glasses were coated for 2 h at 37°C with 100 nM recombinant ICAM1-FC (796IC, R&D Systems) and washed 2 times with PBS ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Neuroscience 2022Quote: ... DIV12 hippocampal neurons were treated with either 2 ug/mL of recombinant Nptx2 (CF 7816-NP-050, R&D Systems) or BSA as control ...
-
bioRxiv - Microbiology 2022Quote: ... Rat collagen I and recombinant human basic fibroblast growth factor (FGF-2) were purchased from R&D Systems (Toronto, ON). Endothelial cell growth basal medium-2 (EBM-2 ...
-
bioRxiv - Immunology 2024Quote: ... and were kept overnight in complete RPMI media with 50 ng/ml of recombinant human IL-2 (R&D Systems). NK cells from HD or MM patients were stimulated in 96 wells plates with plate bound anti-CD16 (clone 3G8 Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... Cells were stained with 25 μL of 0.5 μg/mL primary anti mouse-TLR4 (recombinant monoclonal rabbit IgG, clone #1203B, R&D Systems) or isotype (normal polyclonal rabbit IgG control ...
-
bioRxiv - Immunology 2021Quote: ... recombinant mouse IL-15Rα-Fc and recombinant human IL-15 were purchased from R&D Systems. For each mouse ...
-
bioRxiv - Physiology 2020Quote: Recombinant human Mfge8 and recombinant human laminin subunit alpha-1 were purchased from R&D Systems, www.rndsystems.com ...
-
bioRxiv - Cancer Biology 2022Quote: ... The recombinant cytokines that were used were Recombinant Human GM-CSF Protein (R&D Systems, 215GM), Recombinant Human CCL20/MIP-3α Protein (R&D Systems ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007) or the corresponding controls (0.15% DMSO and PBS 0.5% BSA (Roche #10735086001)) ...
-
bioRxiv - Microbiology 2021Quote: ... Primary antibodies for cleaved caspase-3 (catalog no. MAB835; R&D Systems) and polyclonal rabbit anti-N505 [55] were used at a concentration of 1:800 and 1:1000 respectively ...
-
bioRxiv - Immunology 2022Quote: ... or caspase-9 inhibitors (50 μM Z-LEHD-FMK, R&D Systems), respectively ...
-
bioRxiv - Cell Biology 2022Quote: Human recombinant JAG1 (R&D System) was fluorescently labeled with Alexa Fluor™ 488 Microscale Protein Labeling Kit (Thermo Scientific ...
-
bioRxiv - Immunology 2021Quote: ... Mouse recombinant CXCL13 (R&D Systems) treatment was initiated one day after the tumor inoculation and administered intraperitoneally at 1 µg/mouse every other day for five times ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant TGF-β1 (R&D Systems), and RNASolv reagent (Omega Bio-Tek) ...
-
bioRxiv - Microbiology 2021Quote: ... recombinant human IFNγ (R&D Systems) was also added at varying concentrations ...
-
bioRxiv - Cancer Biology 2020Quote: Recombinant human GDF15 (R&D Systems, Minneapolis ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant mouse VEGFA164 (R&D Systems), was used at 50 ng/ml for in vitro analyses ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant mouse Serpina3n (R&D Systems), at a concentration of 50 or 100 ng/ml ...